Press Releases

Find out the latest announcements and updates from Genialis. This is where you’ll find newest reports on our partnerships, collaborations, and achievements.

October 31, 2019|
Thermo Fisher Scientific, Genialis Ink Comarketing Agreement for RNA-Seq Data Analysis
May 1, 2019|
Genialis Extends NGS Informatics Platform to Analyze Single Cell RNA-Sequencing Data
February 27, 2019|
Roche + Genialis global partnership announcement, ASHG 2018
January 28, 2019|
Genialis, a founding member of the AAIH
January 7, 2019|
Genialis Bolsters Scientific Advisory Board Ahead of IO Biomarker Platform Debut
October 16, 2018|
Genialis Expands Portfolio of Multi-Omics Data Analysis Workflows to Extend Applications for Drug Discovery
November 14, 2017|
Genialis, Inc. Raises $2.3M Seed Round to Advance Visual Exploration of Genomics Data
October 10, 2017|
Baylor, Genialis team up for next generation sequencing

Media Kit

Boilerplate

Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are revolutionizing precision oncology with RNA and AI.